Article
Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations.
PloS one - 1 Jan 2015
Chatziandreou Ilenia, Tsioli Panagiota, Sakellariou Stratigoula, Mourkioti Ioanna, Giannopoulou Ioanna, Levidou Georgia, Korkolopoulou Penelope, Patsouris Efstratios, Saetta Angelica A
Abstract excerpt
BACKGROUND: Selection of NSCLC patients for targeted therapy is currently based upon the presence of sensitizing mutations in EGFR and EML4/ALK translocations. The heterogeneity of molecular alterations in lung cancer has led to the ongoing discovery of potential biomarkers and targets in order to improve survival. AIM: This study aimed to detect alterations in EGFR, KRAS, BRAF, PIK3CA, MET-gene copy number and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
